Enzymes

Recombinant Aeromonas Aminopeptidase (Legacy Tebubio ref. 167100-10). Proteases (also called Proteolytic Enzymes, Peptidases, or Proteinases) are enzymes that hydrolyze the amide bonds within proteins or peptides. Most proteases act in a specific manner, hydrolyzing bonds at, or adjacent to specific residues, or a specific sequence of residues contained within the substrate protein or peptide. Proteases play an important role in most diseases and biological processes, including prenatal and postnatal development, reproduction, signal transduction, the immune response, various autoimmune and degenerative diseases, and cancer. They are also an important research tool, frequently used in the analysis and production of proteins. Recombinant Aeromonas Aminopeptidase is a 31.4 kDa protein containing 291 amino acid residues.

Recombinant Human FGF-23 (Legacy Tebubio ref. 167100-52). The FGF family plays a central role during prenatal development, postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-23, FGF-21 and FGF-19 constitute an atypical FGF subfamily whose ligands act as circulating hormones and require the participation of a Klotho protein as a co-receptor for their signaling. FGF-23 is a bone-derived hormone that acts in the kidney to regulate phosphate homeostasis and vitamin D metabolism. The signaling receptor for FGF-23, a Klotho-FGFR1 (IIIc) complex, is an essential regulator of the renal sodium phosphate co-transporter and key vitamin D-metabolizing enzymes CYP27B1 and CYP24A1. Recombinant Human FGF-23 is a 25.5 kDa globular protein containing 228 amino acid residues.

Recombinant Human FGF-23 (Legacy Tebubio ref. 167100-52). The FGF family plays a central role during prenatal development, postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-23, FGF-21 and FGF-19 constitute an atypical FGF subfamily whose ligands act as circulating hormones and require the participation of a Klotho protein as a co-receptor for their signaling. FGF-23 is a bone-derived hormone that acts in the kidney to regulate phosphate homeostasis and vitamin D metabolism. The signaling receptor for FGF-23, a Klotho-FGFR1 (IIIc) complex, is an essential regulator of the renal sodium phosphate co-transporter and key vitamin D-metabolizing enzymes CYP27B1 and CYP24A1. Recombinant Human FGF-23 is a 25.5 kDa globular protein containing 228 amino acid residues.

Recombinant Human SOD (Legacy Tebubio ref. 167150-10). Superoxide Dismutase 1 (SOD1 or (Cu‐Zn) superoxide dismutase) is the initially discovered mammalian SOD, found in almost all cells, and functioning as an organism’s primary defense against highly toxic reactive oxygen species (ROS). ROS, produced as toxic byproducts of aerobic metabolism, can cause cell damage and apoptosis, and potentially contribute to diseases, including certain heart conditions, degenerative neural diseases, and various oxidative stress and age related disorders. There are three types of mammalian SOD proteins; SOD1, found in the cytoplasm, SOD2 (Mn‐SOD), found in the mitochondria, and SOD3, found in the extracellular space. SOD proteins break down (dismutate) ROS, mainly superoxide, into (non‐toxic) oxygen and (less toxic) peroxide. Subsequently, peroxide is decomposed by other enzymes, most notably, catalase. Various mutations in the SOD1 gene directly correlate with the development of familial amyotrophic la

Recombinant Human SOD (Legacy Tebubio ref. 167150-10). Superoxide Dismutase 1 (SOD1 or (Cu‐Zn) superoxide dismutase) is the initially discovered mammalian SOD, found in almost all cells, and functioning as an organism’s primary defense against highly toxic reactive oxygen species (ROS). ROS, produced as toxic byproducts of aerobic metabolism, can cause cell damage and apoptosis, and potentially contribute to diseases, including certain heart conditions, degenerative neural diseases, and various oxidative stress and age related disorders. There are three types of mammalian SOD proteins; SOD1, found in the cytoplasm, SOD2 (Mn‐SOD), found in the mitochondria, and SOD3, found in the extracellular space. SOD proteins break down (dismutate) ROS, mainly superoxide, into (non‐toxic) oxygen and (less toxic) peroxide. Subsequently, peroxide is decomposed by other enzymes, most notably, catalase. Various mutations in the SOD1 gene directly correlate with the development of familial amyotrophic la

Recombinant Mycoplasma Arginine Deiminase (Legacy Tebubio ref. 167150-12). Arginine Deiminase (ADI) is a microbial enzyme from Mycoplasma produced in E.coli. It has high affinity to L-arginine and hydrolyzes L-arginine to citrulline and ammonia. Low concentrations of ADI have been shown to inhibit proliferation in certain cultured cells by arresting the cell cycle in G1 and/or S phase. Higher concentrations of ADI lead to subsequent apoptosis. Recombinant Mycoplasma Arginine Deiminase is a 46.3 kDa protein consisting of 409 amino acids.

Recombinant Mycoplasma Arginine Deiminase (Legacy Tebubio ref. 167150-12). Arginine Deiminase (ADI) is a microbial enzyme from Mycoplasma produced in E.coli. It has high affinity to L-arginine and hydrolyzes L-arginine to citrulline and ammonia. Low concentrations of ADI have been shown to inhibit proliferation in certain cultured cells by arresting the cell cycle in G1 and/or S phase. Higher concentrations of ADI lead to subsequent apoptosis. Recombinant Mycoplasma Arginine Deiminase is a 46.3 kDa protein consisting of 409 amino acids.

Recombinant Human TIGAR (Legacy Tebubio ref. 167150-14). TIGAR is a p53-inducible enzyme that catalyzes the hydrolysis of fructose-2-6 bisphosphate (F-2-6-BP) to fructose-6-phosphate and inorganic phosphate. F-2-6-BP is a powerful activator of 6-phosphofructose-1 kinase, the rate limiting enzyme of glycolysis. By lowering the intracellular level of F-2-6-BP, TIGAR expression leads to increased glucose processing via the pentose phosphate pathway, the major cellular source for NADPH. Recombinant Human TIGAR expressed in E.coli is a 29.9 kDa protein containing 269 amino acid residues.

Recombinant Human TIGAR (Legacy Tebubio ref. 167150-14). TIGAR is a p53-inducible enzyme that catalyzes the hydrolysis of fructose-2-6 bisphosphate (F-2-6-BP) to fructose-6-phosphate and inorganic phosphate. F-2-6-BP is a powerful activator of 6-phosphofructose-1 kinase, the rate limiting enzyme of glycolysis. By lowering the intracellular level of F-2-6-BP, TIGAR expression leads to increased glucose processing via the pentose phosphate pathway, the major cellular source for NADPH. Recombinant Human TIGAR expressed in E.coli is a 29.9 kDa protein containing 269 amino acid residues.